HUP0202931A2 - Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék - Google Patents

Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék

Info

Publication number
HUP0202931A2
HUP0202931A2 HU0202931A HUP0202931A HUP0202931A2 HU P0202931 A2 HUP0202931 A2 HU P0202931A2 HU 0202931 A HU0202931 A HU 0202931A HU P0202931 A HUP0202931 A HU P0202931A HU P0202931 A2 HUP0202931 A2 HU P0202931A2
Authority
HU
Hungary
Prior art keywords
dispensing device
influenza virus
composition consisting
surface proteins
virus surface
Prior art date
Application number
HU0202931A
Other languages
English (en)
Inventor
André Collioud
R. Glück
U. Glück
Original Assignee
Schweiz. Serum- & Impfinstitut Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7886959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0202931(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schweiz. Serum- & Impfinstitut Bern filed Critical Schweiz. Serum- & Impfinstitut Bern
Publication of HUP0202931A2 publication Critical patent/HUP0202931A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A találmány tárgya egy javított gyógyszerészeti vegyület, valamint egygyógyszer beadására szolgáló javított készülék, melyet egy vegyületorron keresztül történő hatásos beadására van alakítva. Ó
HU0202931A 1998-11-06 1999-11-08 Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék HUP0202931A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19851282A DE19851282A1 (de) 1998-11-06 1998-11-06 Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten
PCT/EP1999/008557 WO2000027430A2 (de) 1998-11-06 1999-11-08 Zusammensetzung bestehend aus influenzavirusoberflächenprotein, und abgabeeinrichtung

Publications (1)

Publication Number Publication Date
HUP0202931A2 true HUP0202931A2 (hu) 2002-12-28

Family

ID=7886959

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202931A HUP0202931A2 (hu) 1998-11-06 1999-11-08 Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék

Country Status (17)

Country Link
EP (1) EP1126875B1 (hu)
JP (1) JP2002529427A (hu)
KR (1) KR20010080955A (hu)
CN (1) CN1331604A (hu)
AT (1) ATE353224T1 (hu)
AU (1) AU776669B2 (hu)
BR (1) BR9915123A (hu)
CA (1) CA2348474C (hu)
CZ (1) CZ20011567A3 (hu)
DE (2) DE19851282A1 (hu)
ES (1) ES2279650T3 (hu)
HR (1) HRP20010300A2 (hu)
HU (1) HUP0202931A2 (hu)
PL (1) PL348202A1 (hu)
SK (1) SK6092001A3 (hu)
WO (1) WO2000027430A2 (hu)
ZA (1) ZA200103607B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
CA2484287A1 (en) * 2002-04-30 2003-11-13 Dnavec Research Inc. Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity
CN100425288C (zh) * 2005-01-28 2008-10-15 北京金迪克生物技术研究所 鼻腔喷雾型流感病毒灭活疫苗及其制备方法
CA2611896A1 (en) 2005-05-18 2006-11-23 Forschungsverbund Berlin E.V. Non-peptidic inhibitors of akap/pka interaction
US20090162320A1 (en) 2005-10-28 2009-06-25 Dnavec Corporation Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
JPWO2007132790A1 (ja) * 2006-05-12 2009-09-24 国立大学法人 北海道大学 細菌菌体成分を含む脂質膜を有するリポソーム
EA020953B1 (ru) * 2007-06-14 2015-03-31 Краселл Свитзерленд Аг Внутрикожная вакцина против гриппа
JP2014140588A (ja) * 2013-01-25 2014-08-07 Shinko Chemical Co Ltd 噴霧容器
WO2019235466A1 (ja) * 2018-06-05 2019-12-12 東興薬品工業株式会社 Ｂ型肝炎ワクチン経鼻投与システム
FR3119772A1 (fr) 2021-02-15 2022-08-19 Aptar France Sas Tête de distribution pour dispositif de distribution nasale d’un produit fluide ou pulvérulent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2434875A (en) * 1945-08-11 1948-01-20 Turnbull Jetting device
FR1257220A (fr) * 1960-02-19 1961-03-31 Dispositif nasal électro-thermique d'inhalation
DE8422872U1 (de) * 1984-08-01 1984-10-25 Anasco GmbH, 6200 Wiesbaden Spender zur intranasalen applikation von fluessigkeiten in form von sprays oder tropfen
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
JP2922935B2 (ja) * 1989-08-11 1999-07-26 東興薬品工業株式会社 粘稠液用鼻孔内噴霧容器の使捨てアダプタ
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
FR2739294B1 (fr) * 1995-09-29 1998-01-16 Lhd Lab Hygiene Dietetique Embout nasal de securite
US5797390A (en) * 1996-03-06 1998-08-25 Mcsoley; Thomas E. Nasal inhaler having a directed spray pattern
FR2764807B1 (fr) * 1997-06-18 1999-08-20 Valois Sa Dispositif de distribution nasale d'un produit fluide ou pulverulent

Also Published As

Publication number Publication date
WO2000027430A3 (de) 2000-11-23
DE19851282A1 (de) 2000-05-11
DE59914183D1 (de) 2007-03-22
KR20010080955A (ko) 2001-08-25
EP1126875B1 (de) 2007-02-07
CN1331604A (zh) 2002-01-16
CZ20011567A3 (cs) 2001-08-15
CA2348474C (en) 2008-01-08
WO2000027430A2 (de) 2000-05-18
ZA200103607B (en) 2003-09-30
ATE353224T1 (de) 2007-02-15
BR9915123A (pt) 2001-07-31
AU776669B2 (en) 2004-09-16
SK6092001A3 (en) 2001-12-03
HRP20010300A2 (en) 2002-06-30
ES2279650T3 (es) 2007-08-16
JP2002529427A (ja) 2002-09-10
CA2348474A1 (en) 2000-05-18
AU1161200A (en) 2000-05-29
EP1126875A2 (de) 2001-08-29
PL348202A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
DK1115384T3 (da) Fentanyl-præparat til behandling af akutte smerter
HUP0100043A2 (hu) Savérzékeny hatóanyagot tartalmazó új gyógyszerforma
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
EE05089B1 (et) Amiidasendatud imidasokinoliinid ja neid sisaldavad farmatseutilised preparaadid
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
BR0011433B1 (pt) Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DK0949925T3 (da) Flad lægemiddelform til anbringelse i mundhulen med frigivelse der af buprenorphin eller et farmakologisk sammenligneligt stof, samt fremgangsmåde til fremstilling deraf
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
HUP0203590A2 (hu) Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
HUP0202862A2 (hu) A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
IS7097A (is) Lyfjablanda til að gefa fúlvestrant í vöðva
DE50115451D1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
NO20014855L (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
GEP20043377B (en) Pharmaceutical Complex
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi